Research Article
Volume 8 Issue 12 - 2020
Complications after One Year of Liver Transplantation among Adult Population
Faisal Al Muqbil1, Mohammad S Shawaqfeh1*, Abdullah Al-Tuwayjiri1, Lilian A Albukiri2, Mohammad Abujamal1, Abdulmalik Alkatheri1,3, Alwaleed R Alrebdi4 and Abdulkareem M Albekairy1,3
1College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
2College of Pharmacy, Prince Sattam University, Al Kharj, Saudi Arabia
3Pharmaceutical Care Services, King Abulaziz Medical City, Riyadh, Saudi Arabia
4College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
*Corresponding Author:Mohammad S Shawaqfeh, Assistant Professor, College of Pharmacy, Department of Pharmacy Practice, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Received: July 21, 2020; Published: November 28, 2020


Background: Liver disease is a major medical problem in Kingdom of Saudi Arabia. Many complications to be encountered after liver transplant range from very serious to less complicated complications and also it differs in the onset of the complication.

Materials and Methods: We have conducted the present observational retrospective chart review study in King Abdulaziz Medical City in Riyadh, Saudi Arabia with a sample of 92 post liver transplantation patients. The following risk factors will be investigated: metabolic syndrome, low levels of high-density lipoprotein, and elevated blood pressure. The diagnosis of acute cellular rejection will be based on histological appearances. Metabolic syndrome is defined by having 3 or more of the following: fasting glucose (≥ 100 mg/dl); abdominal obesity (> 102 cm in men, > 88 cm in women); hypertriglyceridemia (≥ 150 mg/dl); Low levels of high density lipoprotein (HDL) (< 40 mg/dl in men, < 50 mg/dl in women) and elevated blood pressure (≥ 130/85 mmHg). Non-critical care adult inpatients who are recently admitted to the liver transplant center who are eligible for inclusion in this study.

Results: In our present study, we have included 92 patients. There were 6.7% (3 out of 45) patients who developed new onset diabetes mellitus (NODM) in our cohort during the first-year post transplantation. 10.9% (7 out of 64) patients have newly diagnosed with hypertension, and 23.0% (20 out of 87) patients developed Dyslipidemia during the first-year post transplantation.

Conclusion: The percentages of developing diabetes mellitus, hypertension and dyslipidemia are lower than the reported in different studies that might be due to lower rate of using corticosteroids in the maintenance immunosuppressive regimen, or due to intensive follow-up and maintenance immunosuppressive monitoring, or because of the good family and social support in our community. However, the patients were conveniently limited to our medical center.

Keywords: Liver Transplantation; Patients; Risk Factors; Complications; Adult Population


  1. Al Sebayel. “Starting a Liver Transplantation Program: Experience at King Fahad National Guard Hospital in Riyadh”. Annals of Saudi Medicine 4 (1998): 330-332.
  2. Al Sebayel M., et al. “Liver transplantation in the Kingdom of Saudi Arabia”. Liver Transplantation 10 (2017): 1312-1317.
  3. Noun MS., et al. “Hepatitis B virus vs schistosomiasis and hepatocellular carcinoma in Saudi Arabia”. The East African Medical Journal 67 (1990): 139-145.
  4. Moreno R and Berenguer M. “Post-liver transplantation medical complications”. Annals of Hepatology2 (2006): 77-85.
  5. Snowden CP., et al. “Pulmonary edema in patients after liver transplantation”. Liver Transplantation 4 (2000): 466-470.
  6. Rubin DA., et al. “Myocardial ischemia after orthotopic liver transplantation”. The American Journal of Cardiology 1 (1994): 53-56.
  7. Lee SY., et al. “Ventricular fibrillation in a patient with tachycardia-induced cardiomyopathy after liver transplantation”. Korean Circulation Journal 12 (2013): 839-841.
  8. Oliver N., et al. “Post-Liver Transplant Delirium Increases Mortality and Length of Stay”. Ochsner Journal 1 (2017): 25-30.
  9. Fabrizi F., et al. “Chronic kidney disease after liver transplantation: Recent evidence”. The International Journal of Artificial Organs 11 (2010): 803-811.
  10. Lima EQ., et al. “Risk factors for development of acute renal failure after liver transplantation”. Renal Failure4 (2003): 553-660.
  11. Willingham DL., et al. “Unexplained and prolonged perioperative hypotension after orthotopic liver transplantation: undiagnosed systemic mastocytosis”. Liver Transplantation 7 (2009): 701-708.
  12. Akarsu Mesut., et al. “Prevalence and risk factors for obesity after liver transplantation: a single-center experience”. Hepatitis Monthly8 (2013): e7569.
  13. Van Hoek B., et al. “Risk factors for infection after liver transplantation”. Best Practice and Research: Clinical Gastroenterology 1 (2012): 61-72.
  14. Chen HP., et al. “Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study”. PLoS One3 (2016): e0152324.
  15. Lim J., et al. “Risk factors and outcomes associated with alcohol relapse after liver transplantation”. World Journal of Hepatology 17 (2017): 771-780.
  16. Moini M., et al. “Review on immunosuppression in liver transplantation”. World Journal of Hepatology 10 (2015): 1355-1368.
  17. Kallwitz ER. “Metabolic syndrome after liver transplantation: preventable illness or common consequence”. World Journal of Gastroenterology 28 (2012): 3627-3634.
  18. Fisher LR., et al. “Acute cellular rejection after liver transplantation: variability, morbidity, and mortality”. Liver Transplant - Transplant Surgery 1 (1995): 10-15.
  19. Al-Nozha MM., et al. “Obesity in Saudi Arabia”. Saudi Medical Journal 5 (2005): 824-829.
  20. Marchetti P. “New-onset diabetes after liver transplantation: from pathogenesis to management”. Liver Transplantation6 (2005): 612-620.
  21. Ly C., et al. “New-onset diabetes after liver transplantation and its impact on complications and patient survival”. Journal of Diabetes 6 (2015): 881-890.
  22. Imagawa DK., et al. “Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin”. Transplantation 62 (1996): 934-942.
  23. Dopazo C., et al. “Analysis of adult 20-year survivors after liver transplantation”. Hepatology International 3 (2015): 461-470.
  24. Canzanello VJ., et al. “Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506)”. Liver Transplant - Transplant Surgery 4 (1998): 328-334.
  25. Stefano CD., et al. “Risk factors for arterial hypertension after liver transplantation”. Journal of the American Society of Hypertension 3 (2018): 220-229.
  26. Scholte NTB., et al. “In-hospital cardiovascular events after liver transplantation: predictors and long-term outcome”. Netherlands Heart Journal 10 (2018): 506-511.
  27. Dec GW., et al. “Cardiovascular complications following liver transplantation”. Clinical Transplantation 6 (1995): 463-471.
Citation: Mohammad S Shawaqfeh., et al. “Complications after One Year of Liver Transplantation among Adult Population”. EC Pharmacology and Toxicology 8.12 (2020): 51-56.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the January issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for January Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the January issue of respective journals. Submissions are accepted on/before January 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to